Company / Operating Income per Share
Arcutis Biotherapeutics, Inc. Operating Income per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$0.10
FY2025
5-year range
-$5.48 / -$0.10
FY2021-FY2025
Trend
+92.2%
vs FY2024
Sector context
#60 of 201
Health Care
What the data says
At $-0.10, Arcutis Biotherapeutics, Inc.'s operating income per share ranks #60 of 201 in the Health Care sector. Operating Income per Share has increased for 3 consecutive years, from $-5.48 in FY2022 to $-0.10 in FY2025.
Based on SEC 10-K filings.
-0.10 in FY2025.
Improved from $-3.48 to $-0.10 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#60 of 201 in Health CareTop 30% of 201This company -$0.10 Sector average -$3.23
▼
+96.8% above sector average
Key checks
Key Insights
- Arcutis Biotherapeutics, Inc.'s operating income per share has grown for 3 consecutive years.
- In FY2025, operating income per share increased 92.2% year-over-year.
- Ranks #60 out of 201 companies in the Health Care sector.
- Lowest operating income per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -0.65 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.10 | +92.2% |
| FY2024 | -$1.33 | +61.9% |
| FY2023 | -$3.48 | +36.5% |
| FY2022 | -$5.48 | -31.1% |
| FY2021 | -$4.18 | -9.1% |
| FY2020 | -$3.83 | +83.6% |
| FY2019 | -$23.40 | -47.0% |
| FY2018 | -$15.92 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026